Breast cancer patients are the primary population studied in research regarding the prevalence, trajectories, and impact of fear of cancer recurrence, as evidenced by longitudinal studies [1], [2], and [3]. Clinical research consistently measures and tracks these fear levels in breast cancer survivors to understand their impact on quality of life [4], [5], and [6].